Cova Tablets

Cova Tablets – Targeted Protection for the Heart and Arteries

Cova is a therapeutic agent used for the management of several distinct cardiovascular conditions in adults. Its primary indication is for the treatment of essential hypertension, providing reliable and steady blood pressure control. Cova is also highly effective in treating symptomatic heart failure (NYHA class II-IV). It is a preferred choice for heart failure patients who are unable to tolerate or have contraindications to ACE inhibitors, offering an alternative pathway for cardiac protection.

Another critical clinical use of Cova is to improve survival outcomes following a myocardial infarction (heart attack). It is indicated for clinically stable patients who show evidence of left ventricular failure or systolic dysfunction. As an angiotensin II receptor blocker (ARB), it helps prevent the narrowing of blood vessels and reduces the heart's workload. By stabilizing cardiovascular function, Cova significantly lowers the risk of future hospitalizations and cardiac decline. The medication is typically taken once or twice daily, depending on the clinical situation, and is well-tolerated for long-term use. Regular monitoring of kidney function and blood pressure ensures that the patient is receiving the maximum therapeutic benefit safely.

• Indicated for hypertension and chronic heart failure management.
• Improves survival outcomes following a heart attack.
• Suitable for patients who are intolerant to ACE inhibitors.
• Available as: Tablets 80mg and 160mg.